IPHA

AS OF

Nov 19, 12:43 PM (EDT)

Price

$1.82

Change

+$0.02 (+1.11%)

Capitalization

167.63M

120 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

IPHA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Innate Pharma SA (IPHA) Earnings Date & Reports

Innate Pharma SA is a clinical-stage biotechnology company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IPHA is expected to report earnings to fall 52.60% to -14 cents per share on March 19

Innate Pharma SA IPHA Stock Earnings Reports

Q4'25

Est.

$-0.14

Q4'24

Beat

by $0.10

Q2'23

Beat

by $0.16

The last earnings report on March 27 showed earnings per share of -30 cents, beating the estimate of -40 cents. With 5.03K shares outstanding, the current market capitalization sits at 167.63M.

View a ticker or compare two or three

Compare

IPHA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IPHA showed earnings on March 27, 2025. You can read more about the earnings report here.

View AI-Driven Trading for IPHA

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

117, Avenue de Luminy

Phone

+33 430303030

Employees

211

Web

https://www.innate-pharma.com